Records 1 - 30 (of 38 Records)
|Query Trace: Lung Neoplasms and MPO[original query]|
| Counterpoint: the myeloperoxidase -463G-->a polymorphism does not decrease lung cancer susceptibility in Caucasians.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002 Dec 11 (12): 1555-9.
Xu Li-Lian, Liu Geoffrey, Miller David P, Zhou Wei, Lynch Thomas J, Wain John C, Su Li, Christiani David
| [Gene polymorphism of myeloperoxidase and genetic susceptibility to lung cancer].
Ai zheng = Aizheng = Chinese journal of cancer 2003 Sep 22 (9): 912-5.
Wu Xiao-Ming, Zhou Yi-Kai, Ren Shu, Hao Qiao-Li
| Myeloperoxidase promotor polymorphism and risk of hepatoblastoma.
International journal of cancer. Journal international du cancer 2003 Aug 106 (2): 205-7.
Pakakasama Samart, Chen Tina T-L, Frawley William, Muller Carolyn, Douglass Edwin C, Tomlinson Gail
| Myeloperoxidase: new polymorphisms and relation with lung cancer risk.
Pharmacogenetics 2003 Dec 13 (12): 729-39.
Chevrier Isabelle, Stücker Isabelle, Houllier Anne-Marie, Cenée Sylvie, Beaune Philippe, Laurent-Puig Pierre, Loriot Marie-An
| Combined effect of MPO, GSTM1 and GSTT1 polymorphisms on chromosome aberrations and lung cancer risk.
International journal of hygiene and environmental health 2003 Oct 206 (6): 473-83.
Cajas-Salazar Nohelia, Sierra-Torres Carlos H, Salama Salama A, Zwischenberger Joseph B, Au William
| [Lung cancer risk associated with genetic polymorphism in myeloperoxidase (-463 G/A) in a Chinese population].
Zhonghua zhong liu za zhi [Chinese journal of oncology] 2002 May 24 (3): 250-3.
Lu Wenfu, Qi Jun, Xing Deyin, Tan Wen, Miao Xiaoping, Su Wei, Wu Min, Lin Dongx
| Polymorphisms in DNA repair genes, chromosome aberrations, and lung cancer.
Environmental and molecular mutagenesis 2004 44 (1): 74-82.
Harms Carsten, Salama Salama A, Sierra-Torres Carlos H, Cajas-Salazar Nohelia, Au William
| Myeloperoxidase (MPO) -463G->A reduces MPO activity and DNA adduct levels in bronchoalveolar lavages of smokers.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004 May 13 (5): 828-33.
Van Schooten Frederik J, Boots Agnes W, Knaapen Ad M, Godschalk Roger W L, Maas Lou M, Borm Paul J A, Drent Marjolein, Jacobs Jan
| CYP2E1 polymorphism, cigarette smoking, p53 expression, and survival in non-small cell lung cancer: a long term follow-up study.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2004 Dec 12 (4): 315-22.
Haque Abida K, Au William, Cajas-Salazar Nohelia, Khan Shilpi, Ginzel Andrew W, Jones Dennie V, Zwischenberger Joseph B, Xie Jing
| NQO1, MPO, and the risk of lung cancer: a HuGE review.
Genetics in medicine : official journal of the American College of Medical Genetics 2005 Sep 7 (7): 463-78.
Kiyohara Chikako, Yoshimasu Kouichi, Takayama Koichi, Nakanishi Yoic
| Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes.
Cancer genetics and cytogenetics 2005 Oct 162 (1): 10-20.
Chan Eunice C, Lam Shui Y, Fu Kin H, Kwong Yok
| Polymorphisms in genes involved in xenobiotic metabolism and lung cancer risk under the age of 60 years. A pooled study of lung cancer patients in Denmark and Norway.
Lung cancer (Amsterdam, Netherlands) 2005 May 48 (2): 187-99.
Skuladottir Halla, Autrup Herman, Autrup Judith, Tjoenneland Anne, Overvad Kim, Ryberg David, Haugen Aage, Olsen Jørgen
| CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung.
Carcinogenesis 2006 Mar 27 (3): 525-32.
Larsen Jill Everland, Colosimo Maree Louise, Yang Ian Anthony, Bowman Rayleen, Zimmerman Paul Victor, Fong Kwun Me
| Myeloperoxidase -463G>A polymorphism and risk of primary lung cancer in a Korean population.
Cancer detection and prevention 2006 30 (3): 257-61.
Park Jae Hyung, Park Jung Min, Kim Eun Jin, Cha Sung Ick, Lee Eung Bae, Kim Chang Ho, Kam Sin, Jung Tae Hoon, Park Jae Yo
| Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility.
Lung cancer (Amsterdam, Netherlands) 2007 Aug 57 (2): 135-42.
Yang Mihi, Choi Yunhee, Hwangbo Bin, Lee Jin S
| CYP1B1, CYP1A1, MPO, and GSTP1 polymorphisms and lung cancer risk in never-smoking Korean women.
Lung cancer (Amsterdam, Netherlands) 2008 Apr 60 (1): 40-6.
Yoon Kyong-Ah, Kim Jin Hee, Gil Hyea-Jin, Hwang Hyukkee, Hwangbo Bin, Lee Jin S
| A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers.
Carcinogenesis 2008 Jun 29 (6): 1164-9.
Zienolddiny Shanbeh, Campa Daniele, Lind Helge, Ryberg David, Skaug Vidar, Stangeland Lodve B, Canzian Federico, Haugen Aa
| Effect of combined genetic polymorphisms on lung cancer risk in northern Thai women.
Cancer genetics and cytogenetics 2009 Dec 195 (2): 143-9.
Klinchid Jaewwaew, Chewaskulyoung Busyamas, Saeteng Somchareon, Lertprasertsuke Nirush, Kasinrerk Watchara, Cressey Ratcha
| Genetic polymorphisms of MPO, GSTT1, GSTM1, GSTP1, EPHX1 and NQO1 as risk factors of early-onset lung cancer.
International journal of cancer 2010 Oct 127 (7): 1547-61.
Timofeeva Maria, Kropp Silke, Sauter Wiebke, Beckmann Lars, Rosenberger Albert, Illig Thomas, Jäger Birgit, Mittelstrass Kirstin, Dienemann Hendrik, , Bartsch Helmut, Bickeböller Heike, Chang-Claude Jenny, Risch Angela, Wichmann Heinz-Eri
| Myeloperoxidase G-463A polymorphism and risk of lung and prostate cancer in a Turkish population.
Molecular medicine reports 0 4 (1): 87-92.
Arslan Serdal, Pinarbasi Hatice, Silig Yav
| Myeloperoxidase G463A polymorphism and risk of lung cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Jan 35 (1): 821-9.
Li Junrui, Fu Yingju, Zhao Baochun, Xiao Ying, Chen Ruiyi
| Association between myeloperoxidase G-463A polymorphism and lung cancer risk.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Jan 35 (1): 475-81.
Huang Chao, Ma Lu, Li Dej
| Association between MPO 463G>A polymorphism and risk of lung cancer: a meta-analysis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Dec 34 (6): 3449-55.
Zhou Chengzhi, Luo Qun, Qing Yinyin, Lin Xinqing, Zhan Yangqin, Ouyang Mi
| Myeloperoxidase G463A polymorphism and lung cancer risk in Asians: a pooled analysis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Oct 34 (5): 3035-9.
Zhou Yi-yong, Zhang Shao-ming, Cai Zhi-gang, Zhang Heng, Wang Lei, Xu Xiao-ping, Wu Hai-
| The MPO-463G>A polymorphism and lung cancer risk: a meta-analysis based on 22 case-control studies.
PloS one 2013 8 (6): e65778.
Yang Jun-Ping, Wang Wen-Bo, Yang Xiao-Xi, Yang Lei, Ren Li, Zhou Fu-Xiang, Hu Liu, He Wei, Li Bai-Yu, Zhu Yan, Jiang Huan-Gang, Zhou Yun-Fe
| Genetic polymorphisms involved in the inflammatory response and lung cancer risk: a case-control study in Japan.
Cytokine 2014 Jan 65 (1): 88-94.
Kiyohara Chikako, Horiuchi Takahiko, Takayama Koichi, Nakanishi Yoic
| Glutathione S-transferase T1 and myeloperoxidase -463 G>A genotypes in lung cancer patients of Kumaun region.
Journal of natural science, biology, and medicine 2014 Jul 5 (2): 293-6.
Bag Arundhati, Bag Niladri, Jeena Lalit Mohan, Jyala Narayan Sin
| HapMap-based study on the association between MPO and GSTP1 gene polymorphisms and lung cancer susceptibility in Chinese Han population.
Acta pharmacologica Sinica 2014 May 35 (5): 636-44.
Gu Jun-dong, Hua Feng, Mei Chao-rong, Zheng De-jie, Wang Guo-fan, Zhou Qing-h
| Association between MPO-463G?>?A polymorphism and cancer risk: evidence from 60 case-control studies.
World journal of surgical oncology 2017 Aug 15 (1): 144.
Yang Wen-Jun, Wang Ming-Yue, Pan Fu-Ze, Shi Chen, Cen Ho
| Myeloperoxidase -463 G/A polymorphism is associated with lung cancer risk: A meta-analysis with 7420 cases and 9132 controls.
Journal of cancer research and therapeutics 2018 Jun 14 (Supplement): S282-S287.
Zou Shengqiang, Pan Xin, Hua Changsong, Wu Min, He Bin, Chen Zhiga
- Page last reviewed:Oct 1, 2023
- Page last updated:Nov 28, 2023
- Content source: